Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis

doi:10.1084/jem.161.4.755

This Article

	Full Text (PDF, 644K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Adams, J. S.
	Articles by Gacad, M. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Adams, J. S.
	Articles by Gacad, M. A.


Social Bookmarking

	What's this?

ARTICLES

Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis

JS Adams and MA Gacad

We investigated the 1 alpha-hydroxylation of vitamin D3 sterols by cultured pulmonary alveolar macrophages (PAM) from patients with sarcoidosis with or without clinically abnormal calcium homeostasis. Like the naturally occurring renal 1 alpha-hydroxylase, the PAM 1 alpha- hydroxylation reaction exhibited a high affinity for 25-hydroxyvitamin D3 (25-OH-D3) and a preference for substrates containing a 25-hydroxyl group in the side chain of the sterol. Unlike the renal enzyme, the PAM 1 alpha-hydroxylating mechanism was not accompanied by 24-hydroxylating activity, even after preincubation with 75 nM 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3] or exposure to high concentrations of substrate (500 nM 25-OH-D3). The PAM 25-OH-D3-1 alpha-hydroxylation reaction was stimulated by gamma interferon and inhibited by exposure to the glucocorticoid dexamethasone. The characteristics of the PAM hydroxylation process in vitro appear to reflect the efficiency of the extrarenal production of 1,25-(OH)2-D3 and the therapeutic efficacy of glucocorticoids in patients with sarcoidosis and disordered calcium metabolism.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Hansdottir, S., Monick, M. M., Hinde, S. L., Lovan, N., Look, D. C., Hunninghake, G. W. (2008). Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense. J. Immunol. 181: 7090-7099 [Abstract] [Full Text]
Krutzik, S. R., Hewison, M., Liu, P. T., Robles, J. A., Stenger, S., Adams, J. S., Modlin, R. L. (2008). IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway. J. Immunol. 181: 7115-7120 [Abstract] [Full Text]
van Driel, M., Koedam, M., Buurman, C. J., Hewison, M., Chiba, H., Uitterlinden, A. G., Pols, H. A. P., van Leeuwen, J. P. T. M. (2006). Evidence for auto/paracrine actions of vitamin D in bone: 1{alpha}-hydroxylase expression and activity in human bone cells. FASEB J. 20: 2417-2419 [Abstract] [Full Text]
Vanhooke, J. L., Prahl, J. M., Kimmel-Jehan, C., Mendelsohn, M., Danielson, E. W., Healy, K. D., DeLuca, H. F. (2006). CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin. Proc. Natl. Acad. Sci. USA 103: 75-80 [Abstract] [Full Text]
Kinoshita, Y., Taguchi, M., Takeshita, A., Miura, D., Tomikawa, S., Takeuchi, Y. (2005). 1,25-Dihydroxyvitamin D Suppresses Circulating Levels of Parathyroid Hormone in a Patient with Primary Hyperparathyroidism and Coexistent Sarcoidosis. J. Clin. Endocrinol. Metab. 90: 6727-6731 [Abstract] [Full Text]
Dwivedi, P. P, Anderson, P. H, Omdahl, J. L, Grimes, H L., Morris, H. A, May, B. K (2005). Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells. Endocr Relat Cancer 12: 351-365 [Abstract] [Full Text]
Ren, S., Nguyen, L., Wu, S., Encinas, C., Adams, J. S., Hewison, M. (2005). Alternative Splicing of Vitamin D-24-Hydroxylase: A NOVEL MECHANISM FOR THE REGULATION OF EXTRARENAL 1,25-DIHYDROXYVITAMIN D SYNTHESIS. J. Biol. Chem. 280: 20604-20611 [Abstract] [Full Text]
Abreu, M T, Kantorovich, V, Vasiliauskas, E A, Gruntmanis, U, Matuk, R, Daigle, K, Chen, S, Zehnder, D, Lin, Y-C, Yang, H, Hewison, M, Adams, J S (2004). Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53: 1129-1136 [Abstract] [Full Text]
Spach, K. M., Pedersen, L. B., Nashold, F. E., Kayo, T., Yandell, B. S., Prolla, T. A., Hayes, C. E. (2004). Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiol. Genomics 18: 141-151 [Abstract] [Full Text]
Porter, N., Beynon, H.L., Randeva, H.S. (2003). Endocrine and reproductive manifestations of sarcoidosis. QJM 96: 553-561 [Full Text]
Shioi, A., Katagi, M., Okuno, Y., Mori, K., Jono, S., Koyama, H., Nishizawa, Y. (2002). Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells: Roles of Tumor Necrosis Factor-{alpha} and Oncostatin M Derived From Macrophages. Circ. Res. 91: 9-16 [Abstract] [Full Text]
Wang, X., Zhang, M. Y. H., Miller, W. L., Portale, A. A. (2002). Novel Gene Mutations in Patients with 1{alpha}-Hydroxylase Deficiency That Confer Partial Enzyme Activity in Vitro. J. Clin. Endocrinol. Metab. 87: 2424-2430 [Abstract] [Full Text]
Holt, P. R., Arber, N., Halmos, B., Forde, K., Kissileff, H., McGlynn, K. A., Moss, S. F., Fan, K., Yang, K., Lipkin, M. (2002). Colonic Epithelial Cell Proliferation Decreases with Increasing Levels of Serum 25-Hydroxy Vitamin D. Cancer Epidemiol. Biomarkers Prev. 11: 113-119 [Abstract] [Full Text]
Zehnder, D., Bland, R., Williams, M. C., McNinch, R. W., Howie, A. J., Stewart, P. M., Hewison, M. (2001). Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase. J. Clin. Endocrinol. Metab. 86: 888-894 [Abstract] [Full Text]
Buergelt, C. D., Layton, A. W., Ginn, P. E., Taylor, M., King, J. M., Habecker, P. L., Mauldin, E., Whitlock, R., Rossiter, C., Collins, M. T. (2000). The Pathology of Spontaneous Paratuberculosis in the North American Bison (Bison bison). Vet Pathol 37: 428-438 [Abstract] [Full Text]
Conron, M., Young, C., Beynon, H. L. C. (2000). Calcium metabolism in sarcoidosis and its clinical implications. Rheumatology (Oxford) 39: 707-713 [Abstract] [Full Text]
JONES, G., STRUGNELL, S. A., DeLUCA, H. F. (1998). Current Understanding of the Molecular Actions of Vitamin D. Physiol. Rev. 78: 1193-1231 [Abstract] [Full Text]
Rizzato, G. (1998). Clinical impact of bone and calcium metabolism changes in sarcoidosis. Thorax 53: 425-429 [Full Text]
Dusso, A.S., Kamimura, S., Gallieni, M., Zhong, M., Negrea, L., Shapiro, S., Slatopolsky, E. (1997). {gamma}-Interferon-Induced Resistance to 1,25-(OH)2 D3 in Human Monocytes and Macrophages: A Mechanism for the Hypercalcemia of Various Granulomatoses. J. Clin. Endocrinol. Metab. 82: 2222-2232 [Abstract] [Full Text]
Kamimura, S., Gallieni, M., Zhong, M., Beron, W., Slatopolsky, E., Dusso, A. (1995). Microtubules Mediate Cellular 25-Hydroxyvitamin D(3) Trafficking and the Genomic Response to 1,25-Dihydroxyvitamin D(3) in Normal Human Monocytes. J. Biol. Chem. 270: 22160-22166 [Abstract] [Full Text]
Adams, J. S., Diz, M. M., Sharma, O. P. (1989). Effective Reduction in the Serum 1,25-Dihydroxyvitamin D and Calcium Concentration in Sarcoidosis-Associated Hypercalcemia with Short-Course Chloroquine Therapy. ANN INTERN MED 111: 437-438 [Abstract]